Biogen’s third quarter 2019 earnings beat expectations. The company posted earnings of $9.17 per share while our consensus called for EPS of $8.28.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,